U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H24O5
Molecular Weight 404.4551
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OSAJIN

SMILES

CC(C)=CCC1=C2OC(C)(C)C=CC2=C3OC=C(C(=O)C3=C1O)C4=CC=C(O)C=C4

InChI

InChIKey=DCTLJGWMHPGCOS-UHFFFAOYSA-N
InChI=1S/C25H24O5/c1-14(2)5-10-17-21(27)20-22(28)19(15-6-8-16(26)9-7-15)13-29-24(20)18-11-12-25(3,4)30-23(17)18/h5-9,11-13,26-27H,10H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C25H24O5
Molecular Weight 404.4551
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/21532751 | https://www.ncbi.nlm.nih.gov/pubmed/28409880 | https://www.ncbi.nlm.nih.gov/pubmed/16826976

Osajin is the major bioactive isoflavone present in the fruit of Maclura pomifera, commonly referred to as the Osage orange. Osajin have potent cardioprotective effects in perfused rat hearts and kidney subjected to global ischemia and reperfusion. Its effects may be mediated through the inhibition of lipid peroxidation. Osajin can antagonize myocardial injury induced by I/R through inhibiting oxidative stress. Osajin had a noticeable inhibition of AChE with IC(50) values of 2.239 mM.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
6.53 µM [IC50]
23.6 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Antioxidative and EROD activities of osajin and pomiferin.
2004 Mar
Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider.
2009 Aug
[Flavonoids from roots of Flemingia philippinensis].
2009 Mar
Patents

Patents

Sample Use Guides

Osajin was administrated to rats orally in doses of 5, 10 and 20 mg/kg once a day
Route of Administration: Oral
Three different types of human NPC cell lines: TW076 (type 1 NPC, squamous cell carcinoma, EBV negative) [49], CG1 (type 2 NPC, non-keratinizing carcinoma, EBV positive) and TW04 (type 3 NPC, undifferentiated carcinoma, EBV negative) were used for activity evaluation. y, NPC cells were seeded in 96-well plates (56103 /well) and allowed to adhere for 24 h. The medium was then substituted by a fresh one containing different concentrations (0.01–10 mM) of osajin for another 24 h. For the time-course assay, the incubation times with 5 mM of osajin were 6, 12, 24, 36 and 48 h. After incubation, 10 ml of 5 mg/ml of MTT was added to each well and incubated for 4 h at 37uC. Elution of the precipitate was performed with 100 ml of solubilization solution. Cell viability was calculated from absorption values obtained at 570 nm using an automated ELISA reader (Cape Code, UK). All experimental concentrations were performed in triplicate.
Substance Class Chemical
Created
by admin
on Sat Dec 16 20:13:17 GMT 2023
Edited
by admin
on Sat Dec 16 20:13:17 GMT 2023
Record UNII
83R5N9X74B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OSAJIN
INCI   MI  
INCI  
Official Name English
3'-DEOXYPOMIFERIN
Common Name English
5'-O-DEMETHYLSCANDINONE
Common Name English
4H,8H-BENZO(1,2-B:3,4-B')DIPYRAN-4-ONE, 5-HYDROXY-3-(P-HYDROXYPHENYL)-8,8-DIMETHYL-6-(3-METHYL-2-BUTENYL)-
Common Name English
OSAJIN [MI]
Common Name English
4H,8H-BENZO(1,2-B:3,4-B')DIPYRAN-4-ONE, 5-HYDROXY-3-(4-HYDROXYPHENYL)-8,8-DIMETHYL-6-(3-METHYL-2-BUTEN-1-YL)-
Systematic Name English
4H,8H-BENZO(1,2-B:3,4-B')DIPYRAN-4-ONE, 5-HYDROXY-3-(4-HYDROXYPHENYL)-8,8-DIMETHYL-6-(3-METHYL-2-BUTENYL)-
Systematic Name English
OSAJIN [INCI]
Common Name English
NSC-21565
Code English
4H,8H-BENZO(1,2-B:3,4-B)DIPYRAN-4-ONE, 5-HYDROXY-3-(P-HYDROXYPHENYL)-8,8-DIMETHYL-6-(3-METHYL-2-BUTENYL)-
Common Name English
Code System Code Type Description
NSC
21565
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY
CAS
482-53-1
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY
MESH
C485800
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY
FDA UNII
83R5N9X74B
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY
MERCK INDEX
m860
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY Merck Index
PUBCHEM
95168
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID10964028
Created by admin on Sat Dec 16 20:13:17 GMT 2023 , Edited by admin on Sat Dec 16 20:13:17 GMT 2023
PRIMARY